A Phase I/II Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors
A Phase I/II Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors
Not yet recruiting · NCT07847905 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors | Advanced Solid Tumor Cancer | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT07847905 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| LaNova Medicines Limited | 13 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 29 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |
| Hunan Cancer Hospital | Changsha | China | 87 |
| Liaocheng People's Hospital | Liaocheng | China | 16 |
| Taihe Hospital Affiliated Hospital of Hubei University of Medicine | Shiyan | China | 1 |
| The First Affiliated Hospital of Henan Medical University | Xinxiang | China | 6 |
| The First School of Medicine, School of Information and Engineering,The First Affliated Hospital of Wenzhou Medical University | Wenzhou | China | 1 |